First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as GBX 1,809.18 ($22.44) and last traded at GBX 1,808.85 ($22.44), with a volume of 850 shares traded. The stock had previously closed at GBX 1,784.40 ($22.14).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance
The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04. The stock has a market cap of £5.16 billion and a P/E ratio of -1,587.09. The firm’s 50-day moving average is GBX 1,697.91 and its two-hundred day moving average is GBX 1,625.16.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Recommended Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- What Investors Need to Know About Upcoming IPOs
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Ride Out The Recession With These Dividend Kings
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Consumer Discretionary Stocks Explained
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
